Literature DB >> 27098989

Use of conditional centiles of middle cerebral artery pulsatility index and cerebroplacental ratio in the prediction of adverse perinatal outcomes.

Henriette O Karlsen1, Cathrine Ebbing2, Svein Rasmussen1,2, Torvid Kiserud1,2, Synnøve L Johnsen2.   

Abstract

INTRODUCTION: Centiles of middle cerebral artery pulsatility index and cerebroplacental ratio are useful for predicting adverse perinatal outcomes. A 'conditional centile' is conditioned by a previous measurement reflecting degree of individual change over time. Here we test whether such centiles are independent predictors and whether their combination improves prediction.
MATERIAL AND METHODS: This prospective longitudinal study included 220 pregnant women diagnosed with or at risk of having a small-for-gestational-age fetus. Serial Doppler measurements of the umbilical artery and middle cerebral artery pulsatility indexs were used to calculate cerebroplacental ratio. Preterm birth, operative delivery due to fetal distress, admission to neonatal intensive care unit, 5-min Apgar score <7, newborn hypoglycemia, and perinatal mortality were considered adverse outcomes. Possible associations were analyzed by log-binomial regression analysis.
RESULTS: Serial Doppler measurements of the middle cerebral artery were available in 207 participants and cerebroplacental ratio in 205. Conditional centiles ≤5 and ≤10 for both middle cerebral artery pulsatility index and cerebroplacental ratio were associated with increased risk for adverse perinatal outcomes. However, only the combination of cerebroplacental ratio centile and conditional centile ≤10 showed a better performance in the prediction of operative delivery due to fetal distress (p = 0.032), admission to neonatal intensive care unit (p = 0.048), and the combined variable "any adverse outcomes" (p = 0.034) compared with the use of centile ≤10 alone.
CONCLUSIONS: Conditional centile for middle cerebral artery pulsatility index and cerebroplacental ratio ≤5 and ≤10 are associated with adverse perinatal outcomes. When adding conditional centile to conventional centile for cerebroplacental ratio, the prediction improved compared with the use of conventional centile alone.
© 2016 Nordic Federation of Societies of Obstetrics and Gynecology.

Entities:  

Keywords:  Cerebroplacental ratio; conditional centile; middle cerebral artery; perinatal outcomes; pulsatility index

Mesh:

Year:  2016        PMID: 27098989     DOI: 10.1111/aogs.12912

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  4 in total

Review 1.  Clinical Opinion: The diagnosis and management of suspected fetal growth restriction: an evidence-based approach.

Authors:  Christoph C Lees; Roberto Romero; Tamara Stampalija; Andrea Dall'Asta; Greggory A DeVore; Federico Prefumo; Tiziana Frusca; Gerard H A Visser; John C Hobbins; Ahmet A Baschat; Caterina M Bilardo; Henry L Galan; Stuart Campbell; Dev Maulik; Francesc Figueras; Wesley Lee; Julia Unterscheider; Herbert Valensise; Fabricio Da Silva Costa; Laurent J Salomon; Liona C Poon; Enrico Ferrazzi; Giancarlo Mari; Giuseppe Rizzo; John C Kingdom; Torvid Kiserud; Kurt Hecher
Journal:  Am J Obstet Gynecol       Date:  2022-01-10       Impact factor: 10.693

2.  Association Between Fetal Middle Cerebral Artery and Umbilical Artery Doppler Ratio with Fetal Distress in 38-40 Weeks of Gestation.

Authors:  Sara Masihi; Roshan Nikbakht; Mojgan Barati; Mohammad Momen Gharibvand; Azam Jadidi
Journal:  J Obstet Gynaecol India       Date:  2019-07-17

3.  Prediction of neonatal acidosis using the cerebroplacental ratio at different gestational weeks: A case-control study.

Authors:  Lin-Na Guo; Yi-Qing Chai; Shuang Guo; Zhi-Kun Zhang
Journal:  Medicine (Baltimore)       Date:  2019-07       Impact factor: 1.817

4.  The correlation between the cerebroplacental ratio and fetal arterial blood gas in appropriate-for-gestational-age fetuses: A cross-sectional study.

Authors:  Ashraf Jamal; Vajiheh Marsoosi; Fatemeh Sarvestani; Neda Hashemi
Journal:  Int J Reprod Biomed       Date:  2021-10-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.